cbdMD (YCBD) EPS (Weighted Average and Diluted) (2017 - 2025)

cbdMD has disclosed EPS (Weighted Average and Diluted) across 9 years of filings, most recently posting -$0.17 for Q3 2025.

• EPS (Weighted Average and Diluted) for Q3 2025 came in at -$0.17, up 92.11% year-over-year; the trailing twelve-month figure through Sep 2025 was -$0.17 (up 92.11% YoY), and the FY2025 annual result was -$1.09, up 92.39% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.17 for Q3 2025 at cbdMD, up from -$2.14 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q2 2021 to a low of -$11.77 in Q3 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.35 (2021), against an average of -$1.88.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 109.4% in 2021 and tumbled 16717.39% in 2022, its largest moves.
• cbdMD's EPS (Weighted Average and Diluted) stood at -$0.35 in 2021, then soared by 76.54% to -$0.08 in 2022, then sank by 10061.44% to -$8.34 in 2023, then soared by 74.32% to -$2.14 in 2024, then surged by 92.11% to -$0.17 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.17 (Q3 2025), -$2.14 (Q3 2024), and -$0.15 (Q2 2024), per Business Quant data.